February 08, 2016
Gilead Sciences to Participate in Two Upcoming Investor Conferences
- 18th Annual BIO CEO &
Investor Conference -
- Leerink Partners 5th
Annual Global Healthcare Conference -
- Webcasts Available Through Gilead Corporate Website -
FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 8, 2016--
Gilead Sciences, Inc. (Nasdaq: GILD) today announced webcasts from two
upcoming investor conferences: the 18th Annual BIO CEO &
Investor Conference and the Leerink Partners 5th Annual
Global Healthcare Conference, both taking place in New York.
John F. Milligan, PhD, Gilead’s President and Chief Operating Officer,
will participate in fireside chats at the BIO CEO conference on Tuesday,
February 9 at 2:00 p.m. Eastern Time (ET) and the Leerink Partners
conference on Wednesday, February 10 at 8:25 a.m. ET.
The live webcasts can be accessed at the company’s Investors page at www.gilead.com/investors.
Please connect to the company’s website at least 15 minutes prior to the
start of each fireside chat to ensure adequate time for any software
download that may be required to listen to the webcast. The replays will
be available for 14 days following each webcast.
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases. Gilead has operations in more than 30
countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s
website at www.gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160208006066/en/
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936